Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Landos Biopharma, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 10 | 16 | +6 |
| Shares | 1.53M | 1.62M | +96.8K (+6.3%) |
| Value | $5.58M | $34.9M | +$29.3M (+525.5%) |
New holders (7)
Institutions that held Landos Biopharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deltec Asset Management LLC | 50,000 | $1.07M | 0.21% |
| Virtu Financial LLC | 14,537 | $313.0K | 0.02% |
| PenderFund Capital Management Ltd. | 9,300 | $270.8K | 0.07% |
| Black Maple Capital Management LP | 10,405 | $223.5K | 0.15% |
| Tower Research Capital LLC (TRC) | 896 | $19.2K | 0.00% |
| Royal Bank of Canada | 61 | $1.00K | 0.00% |
| Morgan Stanley | 13 | $279 | 0.00% |
Sold out (1)
Institutions that held Landos Biopharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| BlackRock Inc. | 42 | $154 |